Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
6.56
-0.35 (-5.07%)
Jul 30, 2026, 3:04 PM CST
Hunan Hansen Pharmaceutical Company Description
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally.
The company offers medications for digestive, cardiovascular, cerebrovascular, and urological diseases, as well as for traumatology and diagnostic applications.
It provides its products in various forms, including injections, mixtures, tablets, capsules, granules, syrups, decoctions, tinctures, and pills.
Hunan Hansen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Yiyang, China.
Hunan Hansen Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1998 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,108 |
| CEO | Zhengqing Liu |
Contact Details
Address: No. 2688, Yincheng Avenue Yiyang, 413000 China | |
| Phone | 86 737 6351 0790 |
| Website | hansenzy.com |
Stock Details
| Ticker Symbol | 002412 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000PK2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jianghong Dai | Vice President, Chief Financial Officer and Board Secretary |
| Hua Yang | Vice President and MD of Hansen Research |
| Lingsong Ao | Director and Vice President |
| Jianjun Fu | Director and Vice President |
| Ai Hua Liu | Vice President |
| Zhijun Liu | Vice President |
| Zhirong Guo | Accounting Supervisor |